Key facts
- This page summarizes Douglas E. Williams's Form 4 filing for Sana Biotechnology, Inc. (SANA).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 03 Nov 2023, 16:14.
Douglas E. Williams - 02 Nov 2023 Form 4 Insider Report for Sana Biotechnology, Inc. (SANA)
- Reporting relationship
- EVP & President, R&D
- Issuer ticker
- SANA
- Reported as of
- 02 Nov 2023
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 03 Nov 2023, 16:14:01 UTC
- Prior SEC filing
- 11 Apr 2023
- Next SEC filing
- 08 Mar 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Julie Shah, Attorney-in-Fact for Douglas E. Williams
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Douglas E. Williams filed Form 4 for Sana Biotechnology, Inc. (SANA) on 03 Nov 2023.
Change
- Previous filing in this sequence was filed on 11 Apr 2023.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
SANA
transaction
Derivative
Restricted Stock Units
Award
- Transaction value
- $0
- Shares
- +10,000
- Change %
- Price
- $0.000000
- Shares after
- 10,000
- Date
- 02 Nov 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 10,000
- Exercise price
- Footnotes
- F1, F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Each restricted stock unit represents a contingent right to receive one share of Sana Biotechnology, Inc. ("Sana") common stock.
Footnote F2
The restricted stock units will vest in full on January 2, 2025, provided that the reporting person provides continuous service to Sana as an employee, consultant, director or officer of Sana through such date.